| A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer (NCT00352690) | Washington University School of Medicine | 2006-04-01 |
| Study of 3D Radiotherapy With or Without Erlotinib (Tarceva®) in Patients With Localized Non-Small Cell Lung Cancer (NCT00466089) | Hospital of Navarra | 2006-03-01 |
| Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer (NCT00281021) | University of Louisville | 2006-02-01 |
| Pharmaco-economic Study of a Second Line Treatment in Advanced Non Small Cell Lung Cancer (NCT00284778) | University Hospital, Limoges | 2006-02-01 |
| Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy (NCT00290017) | Point Therapeutics | 2006-02-01 |
| A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC) (NCT00300885) | Bayer | 2006-02-01 |
| Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy (NCT00243204) | Point Therapeutics | 2006-01-01 |
| A Phase I/II Clinical Trial of Vorinostat in Combination With Erlotinib for Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer (0683-025) (NCT00251589) | Merck Sharp & Dohme LLC | 2006-01-01 |
| Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC (NCT00294762) | OSI Pharmaceuticals | 2006-01-01 |
| Safety and Efficacy Clinical Study of SNS-595 for Second-Line Therapy in Patients With Advanced NSCLC (NCT00252382) | Sunesis Pharmaceuticals | 2005-12-27 |
| Study of Tarceva and Targretin in Stage I-II Lung Cancer (NCT00125372) | Dartmouth-Hitchcock Medical Center | 2005-12-01 |
| Study Evaluating the Safety Of HKI-272 (Neratinib) In Subjects With Advanced Non-Small Cell Lung Cancer (NCT00266877) | Puma Biotechnology, Inc. | 2005-12-01 |
| Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer (NCT00415818) | Transgene | 2005-12-01 |
| Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLC (NCT00313768) | Pfizer | 2005-12-01 |
| Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC (NCT00254904) | Pfizer | 2005-11-01 |
| Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer (NCT00254891) | Pfizer | 2005-11-01 |
| ABR-217620 in Combination With Docetaxel in Patients With Advanced Non-small Cell Lung Cancer (NCT00132379) | Active Biotech AB | 2005-11-01 |
| A Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small-Cell Lung Cancer (NCT00270582) | Far Eastern Memorial Hospital | 2005-11-01 |
| Ph I:Bevacizumab + Chemotherapy in Pts w/Malig Pleural Effusion Due to Adv NSCLC (NCT00250978) | Memorial Sloan Kettering Cancer Center | 2005-11-01 |
| MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer (NCT00174369) | Pfizer | 2005-11-01 |
| OSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung Cancer (NCT00230126) | Ohio State University Comprehensive Cancer Center | 2005-10-01 |
| Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy (NCT00379665) | Southwestern Regional Medical Center | 2005-10-01 |
| Dose Escalation of BIBF 1120 Combined With Pemetrexed in Advanced Non Small Cell Lung Cancer (NCT02182102) | Boehringer Ingelheim | 2005-09-01 |
| An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma (NCT00207116) | Eli Lilly and Company | 2005-09-01 |
| Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung Cancer (NCT00125359) | Konstantin Dragnev | 2005-08-01 |
| Multimodality Treatment for Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) - BEACON Study: Bevacizumab and Chemotherapy for Operable NSCLC (NCT00130780) | Memorial Sloan Kettering Cancer Center | 2005-08-01 |
| Efficacy and Safety of Oral Treatment With BIBF 1120 ES in Advanced Non-small-cell Lung Cancer (NCT02182050) | Boehringer Ingelheim | 2005-08-01 |
| Pharmacogenomic Study Realized on "Non-small Cell Lung Carcinoma" (NCT00222404) | University Hospital, Grenoble | 2005-07-01 |
| A Dose Escalation Study of BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung Cancer (NCT02182232) | Boehringer Ingelheim | 2005-06-01 |
| ADVANCED Phase II Trial of Weekly vs 3 Weekly Docetaxel and Cisplatin Followed by Gemcitabine in Non-small-cell Lung Cancer (NSCLC) (NCT00424853) | Sanofi | 2005-05-01 |
| Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC) (NCT00153803) | Dartmouth-Hitchcock Medical Center | 2005-05-01 |
| Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC (NCT00268684) | Tel-Aviv Sourasky Medical Center | 2005-05-01 |
| EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide (NCT00132522) | EMD Serono | 2005-05-01 |
| Docetaxel in Non Small Cell Lung Cancer (NSCLC) (NCT00263016) | Sanofi | 2005-05-01 |
| Safety Study of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer (NSCLC) Subjects With Unresectable Stage III Disease (NCT00157196) | Merck KGaA, Darmstadt, Germany | 2005-04-01 |
| VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features (NCT00117351) | Millennium Pharmaceuticals, Inc. | 2005-04-01 |
| Self-Gated Breath-Hold Technique for Helical Tomotherapy in Patients With Non-Small Cell Lung Cancer (NCT00129012) | AHS Cancer Control Alberta | 2005-04-01 |
| Safety and Tolerability of Low-Dose Temozolomide During Whole Brain Radiation in Patients With Cerebral Metastases From Non-Small-Cell Lung Cancer (Study P04071)(TERMINATED) (NCT00266812) | Merck Sharp & Dohme LLC | 2005-03-08 |
| Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer (NCT00145418) | Oncology Specialists, S.C. | 2005-02-01 |
| Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer (NCT00094094) | Pfizer | 2005-02-01 |
| Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer (NCT00147537) | Pfizer | 2005-02-01 |
| Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer (NCT00265200) | University of Louisville | 2005-02-01 |
| Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer (NCT00268151) | University of Louisville | 2005-02-01 |
| Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer (NCT00092001) | Pfizer | 2005-01-01 |
| A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers (NCT00122239) | AHS Cancer Control Alberta | 2005-01-01 |
| Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV (NCT00198393) | Intergroupe Francophone de Cancerologie Thoracique | 2004-11-01 |
| Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum (NCT00094978) | National Cancer Institute (NCI) | 2004-10-25 |
| Phase II Iressa & Carbo/Gem in NSCLC (NCT00264498) | AstraZeneca | 2004-10-01 |
| Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy (NCT00093132) | Agennix | 2004-08-01 |
| Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer (NCT00088556) | Telik | 2004-08-01 |
| Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer (NCT00210171) | Institut Bergonié | 2004-05-01 |
| Trial of Oral Karenitecin in Patients With Solid Tumors and Lung Cancer (NCT00097903) | BioNumerik Pharmaceuticals, Inc. | 2004-05-01 |
| BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC) (NCT00101413) | Bayer | 2004-04-01 |
| Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247) (NCT00076856) | Merck Sharp & Dohme LLC | 2004-03-31 |
| Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC) (NCT00087802) | Sanofi | 2004-03-01 |
| The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer (NCT00215930) | H. Lee Moffitt Cancer Center and Research Institute | 2004-02-01 |
| ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) (NCT00071188) | Genzyme, a Sanofi Company | 2004-02-01 |
| Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer (NCT00622349) | European Lung Cancer Working Party | 2004-02-01 |
| Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC) (NCT00097851) | Cellxpert Biotechnology Corp. | 2004-02-01 |
| Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy (NCT00100256) | Andarix Pharmaceuticals | 2004-01-01 |
| Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer (NCT00540280) | King Faisal Specialist Hospital & Research Center | 2003-10-01 |
| Analysis of Brain Metastasis in Patients With Lung Cancer (NCT00071344) | National Institute of Neurological Disorders and Stroke (NINDS) | 2003-10-01 |
| A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer (NCT00069875) | Eli Lilly and Company | 2003-09-01 |
| A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer (NCT00190840) | Eli Lilly and Company | 2003-09-01 |
| Comparative Trial of Pivanex and Docetaxel Vs Docetaxel Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NCT00073385) | Titan Pharmaceuticals | 2003-09-01 |
| Study Using Induction Chemotherapy and Intensity-Modulated Radiation Therapy Guided by Combined CT and PET Imaging for Patients With Non-Small Cell Lung Cancer (NCT00128999) | Alberta Health services | 2003-09-01 |
| Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer (NCT00066885) | Novacea | 2003-06-01 |
| CPG 7909 Injection in Non-Small Cell Lung Cancer (NCT00070629) | Pfizer | 2003-05-01 |
| This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC. (NCT00059722) | Genzyme, a Sanofi Company | 2003-05-01 |
| Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung Cancer (NCT00139711) | Pfizer | 2003-03-01 |
| Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC (NCT00238615) | Stanford University | 2003-03-01 |
| Combination of Weekly Chest Radiotherapy and Oral Navelbine for the Palliation of Advanced Non Small Cell Lung Cancer: A Phase I Study (NCT00256815) | Clinical Oncology Research Associates | 2003-03-01 |
| A Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC) (NCT00089726) | Cell Genesys | 2003-03-01 |
| Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy. (NCT00061464) | Eli Lilly and Company | 2003-02-01 |
| An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer (NCT00054899) | Epimmune | 2003-01-01 |
| Study of Lonafarnib in Combination With Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer (Study P01901)(TERMINATED) (NCT00050336) | Merck Sharp & Dohme LLC | 2002-12-01 |
| Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Clinical Trial (NCT00061451) | Eli Lilly and Company | 2002-12-01 |
| PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC Patients (NCT00174356) | Pfizer | 2002-12-01 |
| Study for Patients With Non Small Cell Lung Cancer (NSCLC) (NCT00168883) | Charite University, Berlin, Germany | 2002-10-01 |
| Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer (NCT00047801) | Telik | 2002-10-01 |
| Once Weekly Radiation for Lung Cancer With Chemotherapy (NCT00256789) | Clinical Oncology Research Associates | 2002-09-01 |
| PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909) (NCT00043368) | Pfizer | 2002-09-01 |
| A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung Cancer (NCT00191490) | Eli Lilly and Company | 2002-07-01 |
| Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer (NCT00040638) | Telik | 2002-07-01 |
| A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer. (NCT00042679) | Eli Lilly and Company | 2002-06-01 |
| ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial. (NCT00051493) | Eli Lilly and Company | 2002-04-01 |
| Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer (NCT00034164) | Achieve Life Sciences | 2002-04-01 |
| A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer (NCT00034268) | Eli Lilly and Company | 2002-03-01 |
| Trial of Chemotherapy Followed by Pulsed Docetaxel and Concurrent Radiation for Non-Small Cell Lung Cancer (NCT00167401) | University of Rochester | 2002-02-01 |
| A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer (NCT00034827) | Pfizer | 2002-01-01 |
| Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer Patients (NCT00044538) | Bayer | 2001-12-01 |
| OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer (NCT00036647) | OSI Pharmaceuticals | 2001-11-01 |
| Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer (NCT00191230) | Eli Lilly and Company | 2001-09-01 |
| A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer (NCT00153842) | Dartmouth-Hitchcock Medical Center | 2001-08-01 |
| Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer (NCT00191256) | Eli Lilly and Company | 2001-06-01 |
| A Phase II Study of Epothilone Analog BMS-247550 in Patients With Non-Small Cell Lung Cancer Who Have Failed First Line Platinum Based Chemotherapy (NCT00035516) | R-Pharm | 2001-02-01 |
| Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung Cancer (NCT00034541) | Eli Lilly and Company | 2000-12-01 |
| Single Dose Escalation Study of 131I-Sibrotuzumab in Patients With Advanced or Metastatic Non-small Cell Lung Cancer (NCT02209727) | Boehringer Ingelheim | 2000-12-01 |
| Phase 2b Randomized Controlled Study of Tecemotide (L-BLP25) for Immunotherapy of NSCLC (Non-Small Cell Lung Cancer) (NCT00157209) | Merck KGaA, Darmstadt, Germany | 2000-08-01 |
| Trial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung Cancer (NCT00819728) | Sanofi | 2000-06-01 |